Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 126 Breast Neoplasms 78 Neoplasms 48 Prostatic Neoplasms 19 Fatigue 16 Obesity 14 Colorectal Neoplasms 13 Lung Neoplasms 11 Polycystic Ovary Syndrome 10 Colonic Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Head and Neck Neoplasms 7 Weight Loss 6 Ovarian Neoplasms 6 Rectal Neoplasms 5 Multiple Myeloma 5 Lymphedema 5 Leukemia 5 Inflammation 5 Pancreatic Neoplasms 4 Overweight 4 Multiple Endocrine Neoplasia Type 1 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Insulin Resistance 4 Depression 4 Cognitive Dysfunction 4 Brain Neoplasms 4 Stomach Neoplasms 3 Peripheral Nervous System Diseases 3

Interventions

Adalimumab 13 Etanercept 8 Methotrexate 7 Rituximab 6 Abatacept 6 tocilizumab 5 golimumab 5 tofacitinib 4 olokizumab 4 Certolizumab Pegol 4 Tumor Necrosis Factor Inhibitors 3 Infliximab 3 Saline Solution 2 Antirheumatic Agents 2 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 baricitinib 1 Vitamin D 1 Vaccines 1 TACI receptor-IgG Fc fragment fusion protein 1 Syringes 1 Sulfasalazine 1 Sodium Chloride 1 Radioimmunodetection 1 RC-18 1 Pharmaceutical Preparations 1 Lysine Acetyltransferase 5 1 Leflunomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Arthritis, Rheumatoid × Exercise × Clear all

NCT05215509 2024-02-02

RABEX

Rigshospitalet, Denmark

Phase NA Completed

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡